ArticleAnnals of surgical oncology2025

ASO Author Reflections: Is Sentinel Node Biopsy Still of Value for Patients with High-Risk Primary Melanomas Eligible for Adjuvant Immunotherapy?

Thomas E Pennington et al.PubMed ↗Publisher ↗

No numbers read from the abstract.